Owning the disease: A new transformational business model for healthcare

The convergence of expanded access, lower reimbursement rates, higher velocity of innovation, diminished pools of venture capital, the advent of personalized care and a growing demand for improved patient outcomes has created ripples that already are altering the economics and operating dynamics of healthcare.

To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.

Owning the disease: A new transformational business model for healthcare

Look for papers, articles, and case studies. See all thought leadership.